Andrew D. Seidman, MD, and Aditya Bardia, MD, MPH, on Use of Sacituzumab Govitecan in Metastatic Breast Cancer

Posted: Monday, June 18, 2018

Andrew D. Seidman, MD, of Memorial Sloan Kettering Cancer Center, and Aditya Bardia, MD, MPH, of Massachusetts General Hospital, discuss the efficacy of sacituzumab govitecan for treatment-refractory hormone receptor–positive/HER2-negative metastatic breast cancer.